Berkeley, CA · Founded 2022 · Privately Held (backing)
Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. Renasant Bio is based in Berkeley, CA and was founded in 2022. It was valued at $78 million at its seed round in Jun 2025, the last priced event on record. It has raised $55.5 million across 2 recorded rounds; the latest was a $30 million early-stage round in Jun 2025.
PMV mark · valuation
$78.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$55.5M
Last round
Early Stage VC
Jun 2025
Cap table — not yet on record
Renasant Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Renasant Bio with a free account
·Watch Renasant Bio: the Monday email on marks, rounds and moves